Skip to main content
OpenTrials
Completed

NCT Number: NCT02440997

A Preliminary Investigation of the Efficacy of Aromatherapy in Reducing Discomfort in Youth With Chronic Headache

The purpose of this study is to preliminarily establish the extent to which a brief aromatherapy intervention incrementally improves subjective and objective indicators of discomfort (pain, anxiety, and heart rate variability) beyond passive relaxation in youth with chronic headaches. A secondary objective is to establish the safety of using aromatherapy as a treatment strategy in youth with chronic headache. The investigators hypothesize that children randomized to the aromatherapy condition will demonstrate a greater improvement in pain, anxiety, and objectively measured distress (heart rate variability) than comparable children receiving only a passive relaxation treatment (a foot bath). The investigators further hypothesize that the aromatherapy intervention will be safe and well-tolerated by study participants.

Completed

Looking for future studies?

Notify Me

Key information

Age range

7 year–17 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Children's Mercy Hospital

Kansas City, Missouri, 64108, United States

About this study

Complementary and alternative therapies play an increasing role in the multidisciplinary treatment of primary pediatric headache disorders. Every pediatric headache patient needs to have a personalized and tailored program of education, psychological strategies, pharmacotherapy and complementary medicine choices. This particular study may prove desirable for parents of children and adolescents with chronic headache. As documented by Termine, C., Ferrari, Ginevra, O., D'Arrigo, S., Rossi, M., & Lanzi, G. (2005), parents are often uncertain and fearful of submitting their children to treatment with traditional drugs, adolescents can use alternative therapies as a way of affirming their independence, and there are fewer drugs available to treat headache in children. Moreover, there is a 30-40% placebo response in headache sufferers (Mauskop, 2001). Children and adolescents should not be prevented from using alternative treatments, specifically essential oils, provided that the intervention is not harmful or costly. It is hoped this study will contribute to the scant research that exists and help define the indications, effects and limitations of aromatherapy use.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • • Male or female, children and adolescents age 7-17 years of age
  • Diagnosed with status migrainosus or refractory chronic daily headache according to the International Headache Society (ICHD-II) criteria. (A debilitating migraine lasting for more than 72 hours or a headache that lasts hours or may be continuous occurring on > 15 days per month for > 3 months.)
  • No prior history of aromatherapy / essential oil use
  • Able to read, comprehend and complete study procedures. Capable of reading and completing all subjective measures in English
  • Are sufficiently alert to be assessed and communicate
  • Must be compliant with routine medical care and able to perform study-related procedures
  • Provide written informed consent from parent/legal guardian and child assent in accordance with IRB regulations

Exclusion criteria

  • • Known sensitivity to essential oils
  • History of cardiac fibrillation
  • History of G6PD deficiency
  • History of uncontrolled asthma (current, active wheezing)
  • History of diabetes, high blood pressure, epilepsy,
  • Inflammatory or sensory limitations of lower extremities or concurrent lesions of the foot(s)
  • Past or concurrent history of olfactory impairment
  • Concomitant use of propanolol
  • Tobacco use
  • Hepatotoxicity
  • Pregnancy

Treatment and study plan

Aromatherapy

Other

Other names: Mentha piperita

Foot bath

Other

Primary outcomes

  1. improvement in subjective and objective indicators of discomfort

    Time frame: 30 minutes

    pain and anxiety measured subjectively via VAS

  2. improvement in subjective and objective indicators of discomfort

    Time frame: 30 minutes

    heart rate variability measured -10, 10 and 20 minutes

Secondary outcomes

  1. number of Adverse Events

    Time frame: 30 minutes

    assessment of presence or absence of Adverse Events or Serious Adverse Events

Sponsors and collaborators

Lead sponsor

Children's Mercy Hospital Kansas City

Other

Registry information

Important dates

Study start
2015
Primary completion
2017
Study completion
2017
First posted
May 12, 2015
Registry last updated
Apr 10, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.